InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Explore the full record of transactions filed by SCHULMAN AMY W, Director. Insider active across 4 companies, notably Elevance Health, Inc.. Aggregated, 10 disclosures have been logged. Total volume traded: €49k. The latest transaction was disclosed on 13 May 2026 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
0563 shares0
Common Stock
SEC:0001438226-26-000009·
0563 shares0
Common Stock
SEC:0001438226-26-000009:0·
US$674,07511,250 shares@ US$59.9178100.0% of flow
Common Stock
SEC:0001178670-26-000017·
€674,07511,250 shares@ €59.91780.0018% mcap100.0% of flow
Common Stock
SEC:0001178670-26-000017:0·
US$6,47626 shares@ US$249.06410.0000% mcap100.0% of flow
Common Stock
SEC:0001438226-26-000007·
€6,47626 shares@ €249.06410.0000% mcap50.0% of flow
Common Stock
SEC:0001438226-26-000007:0·
€18,05910,091 shares@ €1.789650.4% of flow
Common Stock
SEC:0001209191-21-071110·
€18,05910,091 shares@ €1.789625.2% of flow
Common Stock
SEC:0001209191-21-071110:0·
€17,7941,850 shares@ €9.618249.6% of flow
Common Stock
SEC:0001209191-21-069790·
Ideal exit: 9 Sept 2022 (T+270)
€17,7941,850 shares@ €9.618224.8% of flow
Common Stock
SEC:0001209191-21-069790:0·
Ideal exit: 9 Sept 2022 (T+270)
10 of 10 declarations
About SCHULMAN AMY W
Amy W. Schulman is a Director at Elevance Health, Inc. and Alnylam Pharmaceuticals, Inc. She brings her expertise in strategy and governance to the board. Elevance Health is a healthcare services company, while Alnylam Pharmaceuticals focuses on developing innovative therapies. Ms. Schulman plays an active role in strategic direction and oversight of the companies' operations.
